Literature DB >> 15723074

EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.

Jörg Dietrich1, Michelle Lacagnina, David Gass, Eric Richfield, Margot Mayer-Pröschel, Mark Noble, Carlos Torres, Christoph Pröschel.   

Abstract

Vanishing white matter disease (VWM) is a heritable leukodystrophy linked to mutations in translation initiation factor 2B (eIF2B). Although the clinical course of this disease has been relatively well described, the cellular consequences of EIF2B mutations on neural cells are unknown. Here we have established cell cultures from the brain of an individual with VWM carrying mutations in subunit 5 of eIF2B (encoded by EIF2B5). Despite the extensive demyelination apparent in this VWM patient, normal-appearing oligodendrocytes were readily generated in vitro. In contrast, few GFAP-expressing (GFAP+) astrocytes were present in primary cultures, induction of astrocytes was severely compromised, and the few astrocytes generated showed abnormal morphologies and antigenic phenotypes. Lesions in vivo also lacked GFAP+ astrocytes. RNAi targeting of EIF2B5 severely compromised the induction of GFAP+ cells from normal human glial progenitors. This raises the possibility that a deficiency in astrocyte function may contribute to the loss of white matter in VWM leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723074     DOI: 10.1038/nm1195

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  47 in total

Review 1.  Brain connexins in demyelinating diseases: therapeutic potential of glial targets.

Authors:  Maria Luisa Cotrina; Maiken Nedergaard
Journal:  Brain Res       Date:  2012-07-10       Impact factor: 3.252

Review 2.  Myelination and support of axonal integrity by glia.

Authors:  Klaus-Armin Nave
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

4.  Late onset vanishing white matter disease.

Authors:  Axel Riecker; Thomas Nägele; Marco Henneke; Ludger Schöls
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

5.  Astrocytes are an early target in osmotic demyelination syndrome.

Authors:  Fabrice Gankam Kengne; Charles Nicaise; Alain Soupart; Alain Boom; Johan Schiettecatte; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

6.  Astrocyte phenotypes and their relationship to myelination.

Authors:  Besma Nash; Kalliopi Ioannidou; Susan C Barnett
Journal:  J Anat       Date:  2010-12-24       Impact factor: 2.610

7.  Stratification of astrocytes in healthy and diseased brain.

Authors:  Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 8.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

9.  MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells.

Authors:  Brian S Letzen; Cyndi Liu; Nitish V Thakor; John D Gearhart; Angelo H All; Candace L Kerr
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

10.  Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.

Authors:  Laetitia Horzinski; Liraz Kantor; Aurélia Huyghe; Raphael Schiffmann; Orna Elroy-Stein; Odile Boespflug-Tanguy; Anne Fogli
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.